Главная › Немелкоклеточный рак легкого › Вирджиния › Arlington
Клинические исследования Немелкоклеточный рак легкого в городе Arlington, VA
104 исследований по теме Немелкоклеточный рак легкого ищут участников в центрах в городе Arlington и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набор участниковФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 миль отсюда
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Набор участниковФаза 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11 миль отсюда
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Набор участниковФаза 2/3
- Virginia Cancer Specialists, PC, Fairfax · 11 миль отсюда
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Inova Schar Cancer Institute, Fairfax · 11 миль отсюда
- NEXT Virginia, Fairfax · 11 миль отсюда
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Набор участниковФаза 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11 миль отсюда
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набор участниковФаза 1
- ALX Center 2, Fairfax · 11 миль отсюда
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Набор участниковФаза 1
- Site 04, Fairfax · 11 миль отсюда
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Набор участниковФаза 2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набор участниковФаза 3
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Набор участниковФаза 3
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- PHN-012-001 Site, Fairfax · 11 миль отсюда
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Набор участниковФаза 2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 1
- Virginia Cancer Specialists PC, Fairfax · 11 миль отсюда
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Набор участниковФаза 2
- Research Site, Fairfax · 11 миль отсюда
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Набор участниковФаза 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набор участниковФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11 миль отсюда
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Набор участниковФаза 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 миль отсюда
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набор участниковФаза 1
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набор участниковФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 миль отсюда
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 3
- Research Site, Fairfax · 11 миль отсюда
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набор участниковФаза 3
- Clinical Study Site, Fairfax · 11 миль отсюда
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Набор участниковФаза 3
- Virginia Cancer Specialists, Arlington
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набор участниковФаза 1
- NEXT - Virginia, Fairfax · 11 миль отсюда
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Набор участниковФаза 3
- Virginia Cancer Specialists, PC, Fairfax · 11 миль отсюда
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набор участниковФаза 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 миль отсюда
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Набор участниковФаза 1/2
- Inova Schar Cancer Institute, Fairfax · 11 миль отсюда
- Next Oncology Virginia, Fairfax · 11 миль отсюда
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · 11 миль отсюда
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набор участниковФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набор участниковФаза 3
- USO - Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 миль отсюда
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набор участниковФаза 3
- Research Site, Fairfax · 11 миль отсюда
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Набор участниковФаза 1
- NEXT Oncology, Fairfax · 11 миль отсюда
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Набор участниковФаза 1
- Virginia Cancer Specialists, PC, Fairfax · 11 миль отсюда
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Набор участниковФаза 1
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Набор участниковФаза 3
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Набор участниковФаза 2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, Fairfax · 11 миль отсюда
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Набор участниковФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 миль отсюда
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Research Site, Fairfax · 11 миль отсюда
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набор участниковФаза 3
- Inova Schar Cancer Institute, Fairfax · 11 миль отсюда
- Inova Fair Oaks Hospital, Fairfax · 11 миль отсюда
A Study of DM005 in Patients With Advanced Solid Tumors
Набор участниковФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Clinical Trial Site, Fairfax · 11 миль отсюда
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Набор участниковФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Next Virginia, Fairfax · 11 миль отсюда
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Набор участниковФаза 3
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Набор участниковФаза 1/2
- Research Site, Fairfax · 11 миль отсюда
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набор участниковФаза 1
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Research Site, Fairfax · 11 миль отсюда
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Набор участниковФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Набор участниковФаза 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 миль отсюда
A Study of LY4175408 in Participants With Advanced Cancer
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
Study of XB010 in Subjects With Solid Tumors
Набор участниковФаза 1
- Inova Schar Cancer, Fairfax · 11 миль отсюда
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Набор участниковФаза 1
- NEXT Texas LLC - Virginia, Fairfax · 11 миль отсюда
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Research Site, Fairfax · 11 миль отсюда
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набор участниковФаза 1
- Research Site, Fairfax · 11 миль отсюда
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 миль отсюда
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набор участниковФаза 1
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Набор участниковФаза 1/2
- NEXT Oncology, Fairfax · 11 миль отсюда
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Набор участниковФаза 3
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набор участниковФаза 1
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набор участниковФаза 1/2
- Next Oncology Virginia, Fairfax · 11 миль отсюда
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, Fairfax · 11 миль отсюда
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 миль отсюда
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 миль отсюда
A 2-part Phase 1/2 Open-label Trial on ODM-212
Набор участниковФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 миль отсюда
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Набор участниковФаза 2
- Inova Fairfax Hospital, Fairfax · 11 миль отсюда
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Набор участниковФаза 1
- Research Site, Fairfax · 11 миль отсюда
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- NEXT Virginia, Fairfax · 11 миль отсюда
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Набор участниковФаза 1/2
- NEXT, Virginia, Fairfax · 11 миль отсюда
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Набор участниковФаза 1
- Dren Investigational Site, Fairfax · 11 миль отсюда
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Набор участниковФаза 1
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Набор участниковФаза 1
- NEXT Oncology, Fairfax · 11 миль отсюда
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Набор участниковФаза 1/2
- Research Site 102, Fairfax · 11 миль отсюда
- Research Site 112, Fairfax · 11 миль отсюда
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Набор участниковФаза 2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Набор участниковФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 миль отсюда
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Набор участниковФаза 1/2
- NEXT Virginia, Fairfax · 11 миль отсюда
Исследования Немелкоклеточный рак легкого в других городах
- Houston, TX145 исследований
- New York City, NY120 исследований
- Nashville, TN97 исследований
- Boston, MA90 исследований
- Los Angeles, CA87 исследований
- St. Louis, MO73 исследований
- Chicago, IL61 исследование
- Baltimore, MD60 исследований
- San Antonio, TX59 исследований
- Columbus, OH56 исследований
- Washington, DC55 исследований
- Seattle, WA53 исследований
Другие исследования в городе Arlington
- Метастатический рак53 исследований
- Колоректальный рак52 исследований
- Рак (все виды)48 исследований
- Рак молочной железы46 исследований
- Рак яичников46 исследований
- Рак легких41 исследование
- Рак эндометрия39 исследований
- Рак поджелудочной железы33 исследований
- Плоскоклеточный рак головы и шеи26 исследований
- Мелкоклеточный рак легкого23 исследований
- Тройной негативный рак молочной железы20 исследований
- Рак желудка20 исследований
Источник: ClinicalTrials.gov, данные получены 5 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.